Skip to content
10-Q

Quarterly Report

AUXILIUM PHARMACEUTICALS INC

0001104659-14-075030

← back to feed
Filed
Oct 30, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Oct 27, 2014 51.02M sh
Shares Diluted Q3 2014 · Sep 30, 2014 50.4M sh
Shares Diluted Q3 2014 · Sep 30, 2014 50.15M sh
Shares Diluted Q3 2014 · Sep 30, 2013 49.38M sh
Shares Diluted Q3 2014 · Sep 30, 2013 49.61M sh
Stock Repurchased Q3 2014 · Sep 30, 2014 $1.03M
Stock Repurchased Q3 2014 · Sep 30, 2013 $139K
Capex Q3 2014 · Sep 30, 2014 $7.47M
Capex Q3 2014 · Sep 30, 2013 $7.79M
Long Term Debt Q3 2014 · Sep 30, 2014 $278.41M
Long Term Debt Q3 2014 · Dec 31, 2013 $241.54M
Short Term Debt Q3 2014 · Sep 30, 2014 $16.93M
Short Term Debt Q3 2014 · Dec 31, 2013 $13.61M
Short Term Investments Q3 2014 · Sep 30, 2014 $3.84M
Short Term Investments Q3 2014 · Dec 31, 2013 $23.44M
Cash And Equivalents Q3 2014 · Sep 30, 2014 $74.03M
Cash And Equivalents Q3 2014 · Dec 31, 2013 $47.75M
Cash And Equivalents Q3 2014 · Sep 30, 2013 $91.01M
Cash And Equivalents Q3 2014 · Dec 31, 2012 $35.86M
Stockholders Equity Q3 2014 · Sep 30, 2014 $161.88M
Stockholders Equity Q3 2014 · Dec 31, 2013 $251.47M
Current Liabilities Q3 2014 · Sep 30, 2014 $208M
Current Liabilities Q3 2014 · Dec 31, 2013 $196.5M
Total Liabilities Q3 2014 · Sep 30, 2014 $983.1M
Total Liabilities Q3 2014 · Dec 31, 2013 $949.71M
Current Assets Q3 2014 · Sep 30, 2014 $262.03M
Current Assets Q3 2014 · Dec 31, 2013 $238.59M
Total Assets Q3 2014 · Sep 30, 2014 $1.14B
Total Assets Q3 2014 · Dec 31, 2013 $1.2B
Eps Diluted Q3 2014 · Sep 30, 2014 −$0.65
Eps Diluted Q3 2014 · Sep 30, 2014 −$2.49
Eps Diluted restated Q3 2014 · Sep 30, 2013 −$0.58
Eps Diluted restated Q3 2014 · Sep 30, 2013 $0.12
Eps Basic Q3 2014 · Sep 30, 2014 −$0.65
Eps Basic Q3 2014 · Sep 30, 2014 −$2.49
Eps Basic restated Q3 2014 · Sep 30, 2013 −$0.58
Eps Basic restated Q3 2014 · Sep 30, 2013 $0.12
Sga Expense Q3 2014 · Sep 30, 2014 $72.49M
Sga Expense Q3 2014 · Sep 30, 2014 $219.71M
Sga Expense Q3 2014 · Sep 30, 2013 $62.81M
Sga Expense Q3 2014 · Sep 30, 2013 $182.01M
Rd Expense Q3 2014 · Sep 30, 2014 $11.22M
Rd Expense Q3 2014 · Sep 30, 2014 $33.52M
Rd Expense Q3 2014 · Sep 30, 2013 $11.82M
Rd Expense Q3 2014 · Sep 30, 2013 $37.3M
Operating Income Q3 2014 · Sep 30, 2014 −$23.2M
Operating Income Q3 2014 · Sep 30, 2014 −$96.42M
Operating Income Q3 2014 · Sep 30, 2013 −$19.79M
Operating Income Q3 2014 · Sep 30, 2013 −$53.25M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $25.71M
Cost Of Revenue Q3 2014 · Sep 30, 2014 $73.9M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $33.55M
Cost Of Revenue Q3 2014 · Sep 30, 2013 $75.86M